Who We Are
Omni Biotech Innovations is a Canadian based, early-stage drug discovery company focused on developing differentiated antibodies for the treatment of autoimmune diseases. The prevelance is high and rising, however, the current therapies still suffer from low remission rates and serious side effects. While bispecific & multi-specific antibody approaches have shown promise in cancer treatment, they remain under-explored in autoimmune disorders, presenting a unique opportunity for us.
We have all the conditions to develop best-in-class therapies:
Experienced Team
We are guided by experienced founders with complementary expertise in antibody engineering, immunology, BD, and drug development.
State-of-the-Art Facility
We operate from a 16,000 sq. ft. state-of-the-art facility, enabling advanced drug discovery and end-to-end development.
Patient-Driven Science
Our work is driven by our core mission to bring safe and effective medicines to autoimmune disease patients with the greatest unmet needs.
